Literature DB >> 8527014

Drug interactions of clinical importance. An updated guide.

D I Quinn1, R O Day.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 8527014     DOI: 10.2165/00002018-199512060-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  15 in total

Review 1.  Nonsteroidal anti-inflammatory drugs and antihypertensives. Cooperative malfeasance.

Authors:  M Z Sahloul; R al-Kiek; P Ivanovich; S K Mujais
Journal:  Nephron       Date:  1990       Impact factor: 2.847

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Interactions with selective MAOIs.

Authors:  M G Livingston
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

Review 4.  Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

Authors:  J B Houston
Journal:  Biochem Pharmacol       Date:  1994-04-29       Impact factor: 5.858

5.  Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.

Authors:  H Lefebvre; C Noblet; N Moore; L M Wolf
Journal:  Clin Endocrinol (Oxf)       Date:  1995-01       Impact factor: 3.478

6.  Toxic serotonin syndrome after fluoxetine plus carbamazepine.

Authors:  S M Dursun; V M Mathew; M A Reveley
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

7.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

8.  Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.

Authors:  P K Honig; R L Woosley; K Zamani; D P Conner; L R Cantilena
Journal:  Clin Pharmacol Ther       Date:  1992-09       Impact factor: 6.875

Review 9.  Epidemiology of drug-drug interactions as a cause of hospital admissions.

Authors:  C A Jankel; L K Fitterman
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 10.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

View more
  5 in total

Review 1.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 2.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 4.  Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Authors:  E H Heinonen; V Myllylä
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

5.  DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels.

Authors:  Cheng Yan; Guihua Duan; Yi Pan; Fang-Xiang Wu; Jianxin Wang
Journal:  BMC Bioinformatics       Date:  2019-12-24       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.